Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation: Meta-Analysis
about
Reversal agents for NOACs: Connecting the dotsAsian Patients with Stroke plus Atrial Fibrillation and the Dose of Non-Vitamin K Oral AnticoagulantsEdoxaban in venous thromboembolism and stroke prevention: an appraisalEmerging Tools for Stroke Prevention in Atrial FibrillationDOACs - advances and limitations in real worldComparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort studyAssessing bleeding risk in 4824 Asian patients with atrial fibrillation: The Beijing PLA Hospital Atrial Fibrillation Project2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation.Effectiveness and Safety of Standard-Dose Nonvitamin K Antagonist Oral Anticoagulants and Warfarin Among Patients With Atrial Fibrillation With a Single Stroke Risk Factor: A Nationwide Cohort Study.Drug Treatment of Venous Thromboembolism in the Elderly.Risk of gastrointestinal bleeding during anticoagulant treatment.Bleeding risk with dabigatran, rivaroxaban, warfarin, and antiplatelet agent in Asians with non-valvular atrial fibrillation.Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation.Difference between the Upper and the Lower Gastrointestinal Bleeding in Patients Taking Nonvitamin K Oral Anticoagulants.Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry: protocol for a prospective, observational nationwide cohort study.
P2860
Q26740248-FC5B4496-7291-448F-AAD4-E64B1C349965Q26750467-C1EA91ED-6100-48A7-91E5-9FB473C6E7C0Q26751263-D37EFAD1-6DC3-43D6-9851-30E3B4D16746Q26765023-F8484648-19B2-417B-BB26-B465B2A2E6D6Q28070132-E518BE06-21F6-407B-BDD2-B5DF3F0ABFC6Q37012525-397DAFEE-B77D-4FA8-A731-D059DBBB8CD2Q37202504-C0C00E7F-14E0-4544-A84F-51C518AEEDF8Q38647787-028F0541-09F9-4FE6-A3ED-15B09222B3B2Q38725712-21F25177-6D24-499C-AF5F-9982F1210A46Q38851927-751A9787-BAB0-43D4-A1DC-443766968EDCQ39280394-2AB2F961-0B26-442F-B2DD-E5CB4F6013BCQ47097414-77A70C6E-B361-4970-A82D-1ABC7913FBB1Q52603891-535DC6BE-AA87-4CD1-A155-BCFC10663A08Q55026261-FA888BD0-CE2C-4F3E-AB48-6C809263A94EQ55283286-779B7FF7-F525-46ED-A03D-9D3ADA50DD00
P2860
Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation: Meta-Analysis
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Non-Vitamin K Antagonist Oral ...... al Fibrillation: Meta-Analysis
@ast
Non-Vitamin K Antagonist Oral ...... al Fibrillation: Meta-Analysis
@en
type
label
Non-Vitamin K Antagonist Oral ...... al Fibrillation: Meta-Analysis
@ast
Non-Vitamin K Antagonist Oral ...... al Fibrillation: Meta-Analysis
@en
prefLabel
Non-Vitamin K Antagonist Oral ...... al Fibrillation: Meta-Analysis
@ast
Non-Vitamin K Antagonist Oral ...... al Fibrillation: Meta-Analysis
@en
P2093
P2860
P1433
P1476
Non-Vitamin K Antagonist Oral ...... al Fibrillation: Meta-Analysis
@en
P2093
Chern-En Chiang
Kang-Ling Wang
Shing-Jong Lin
P2860
P304
P356
10.1161/STROKEAHA.115.009947
P407
P577
2015-07-30T00:00:00Z